ADALIMUMAB-AATY

ADALIMUMAB-AATY was reported 49626 times

ADALIMUMAB-AATY is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 476 0.7126
1 LUPUS VULGARIS 846 0.6714
2 GRIP STRENGTH 139 0.6070
3 RED BLOOD CELL SEDIMENTATION RATE 167 0.5986
4 CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS 67 0.5583
5 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 185 0.5506
6 DEEP VEIN THROMBOSIS POSTOPERATIVE 1085 0.5417
7 SYNOVIAL FLUID ANALYSIS 46 0.5287
8 HEPATIC ENZYME 77 0.5168
9 SWOLLEN JOINT COUNT INCREASED 1635 0.5122
10 C-REACTIVE PROTEIN 459 0.4951
11 RHEUMATIC FEVER 2194 0.4917
12 FACET JOINT SYNDROME 1544 0.4738
13 HYPOCHOLESTEROLAEMIA 160 0.4533
14 SWOLLEN JOINT COUNT 111 0.4440
15 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 919 0.4431
16 PARADOXICAL PSORIASIS 202 0.4307
17 RETINITIS 707 0.4089
18 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 2809 0.3917
19 DISLOCATION OF VERTEBRA 883 0.3868
20 RHEUMATOID FACTOR POSITIVE 2161 0.3737
21 X-RAY ABNORMAL 665 0.3715
22 DUODENAL ULCER PERFORATION 2739 0.3679
23 MUSCULOSKELETAL DEFORMITY 86 0.3675
24 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 201 0.3583
25 ILEOCAECAL RESECTION 102 0.2965
26 BODY HEIGHT BELOW NORMAL 189 0.2939
27 PEMPHIGUS 3637 0.2906
28 C-REACTIVE PROTEIN ABNORMAL 1821 0.2836
29 SERONEGATIVE ARTHRITIS 325 0.2836
30 PERIPHERAL VENOUS DISEASE 1151 0.2816
31 HELICOBACTER INFECTION 2767 0.2690
32 HAND DEFORMITY 3483 0.2653
33 SHORT STATURE 69 0.2634
34 CUTANEOUS LEISHMANIASIS 66 0.2609
35 VAGINAL FLATULENCE 76 0.2508
36 FOLLICULITIS 2621 0.2497
37 MUSCLE INJURY 2045 0.2466
38 STEROID DEPENDENCE 213 0.2426
39 BONE EROSION 821 0.2319
40 SYNOVITIS 3973 0.2201
41 AMAUROSIS FUGAX 236 0.2191
42 LOOSE BODY IN JOINT 58 0.2180
43 SARCOID-LIKE REACTION 55 0.2132
44 BREAST CANCER STAGE III 1333 0.2056
45 JOINT DESTRUCTION 314 0.2018
46 ENTHESOPATHY 307 0.1962
47 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1257 0.1934
48 TERMINAL ILEITIS 118 0.1922
49 JUVENILE IDIOPATHIC ARTHRITIS 459 0.1875
50 ANKLE ARTHROPLASTY 65 0.1791
51 PERICARDITIS 2999 0.1783
52 SAPHO SYNDROME 44 0.1781
53 PORPHYRIA ACUTE 254 0.1770
54 LIP DRY 1559 0.1715
55 CATARRH 155 0.1715
56 GRANULOMA SKIN 139 0.1693
57 GLOSSODYNIA 3785 0.1689
58 GRIP STRENGTH DECREASED 1484 0.1684
59 HYPERCHOLESTEROLAEMIA 1592 0.1647
60 PALMOPLANTAR PUSTULOSIS 86 0.1626
61 JOINT RANGE OF MOTION DECREASED 2095 0.1561
62 DRUG TOLERANCE DECREASED 438 0.1558
63 MYCOBACTERIUM MARINUM INFECTION 50 0.1538
64 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 354 0.1535
65 WOUND INFECTION 1681 0.1533
66 ONYCHOMADESIS 640 0.1523
67 BURSITIS 1757 0.1447
68 FAECAL CALPROTECTIN ABNORMAL 60 0.1446
69 PROCTOCOLECTOMY 43 0.1410
70 BLEPHAROSPASM 872 0.1383
71 DRUG SPECIFIC ANTIBODY 187 0.1365
72 GENERALISED PUSTULAR PSORIASIS 39 0.1345
73 IRIS ADHESIONS 68 0.1326
74 PLASMABLASTIC LYMPHOMA 47 0.1313
75 LIVE BIRTH 1085 0.1296
76 POLYCHONDRITIS 54 0.1280
77 ANASTOMOTIC STENOSIS 47 0.1263
78 WOUND 3435 0.1228
79 SYSTEMIC LUPUS ERYTHEMATOSUS 4230 0.1191
80 AUTOIMMUNE DISORDER 1146 0.1175
81 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1292 0.1166
82 PYODERMA GANGRENOSUM 414 0.1150
83 NEUROSARCOIDOSIS 43 0.1144
84 FIBROMYALGIA 2763 0.1135
85 IRRITABLE BOWEL SYNDROME 2410 0.1123
86 CONTRAINDICATED PRODUCT ADMINISTERED 3372 0.1113
87 BLOOD PARATHYROID HORMONE DECREASED 163 0.1099
88 MEAN PLATELET VOLUME DECREASED 92 0.1097
89 FINGER DEFORMITY 517 0.1066
90 ANTIBODY TEST POSITIVE 177 0.1066
91 DISSEMINATED TUBERCULOSIS 273 0.1063
92 VASCULAR ACCESS COMPLICATION 86 0.1062
93 ONYCHOMYCOSIS 463 0.1054
94 DEATH NEONATAL 145 0.1042
95 INFUSION SITE REACTION 309 0.1033
96 TENOSYNOVITIS 285 0.1032
97 LUPUS-LIKE SYNDROME 935 0.1030
98 HEPATOSPLENIC T-CELL LYMPHOMA 38 0.1024
99 ARTHRITIS ENTEROPATHIC 33 0.1012
100 NAIL DISORDER 880 0.1005
101 POLYARTHRITIS 528 0.1001
102 LIVER INJURY 2433 0.0990
103 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS 33 0.0985
104 SACROILIITIS 185 0.0979
105 PSORIATIC ARTHROPATHY 3926 0.0966
106 OBESITY 1523 0.0955
107 RHEUMATOID LUNG 90 0.0942
108 TENOSYNOVITIS STENOSANS 52 0.0934
109 PANNICULITIS 224 0.0925
110 RHEUMATOID NODULE 254 0.0921
111 PUSTULAR PSORIASIS 312 0.0908
112 VISCERAL LEISHMANIASIS 64 0.0886
113 BURNS SECOND DEGREE 155 0.0883
114 FAECAL CALPROTECTIN INCREASED 273 0.0861
115 EXOSTOSIS 782 0.0855
116 CHRONIC CUTANEOUS LUPUS ERYTHEMATOSUS 38 0.0848
117 VULVAL DISORDER 56 0.0847
118 TYPE 2 DIABETES MELLITUS 2800 0.0831
119 BONE DENSITY INCREASED 33 0.0827
120 SPONDYLOARTHROPATHY 49 0.0817
121 LOSS OF THERAPEUTIC RESPONSE 255 0.0799
122 ILEAL ULCER 80 0.0791
123 OVERLAP SYNDROME 55 0.0786
124 PRODUCT LABEL CONFUSION 458 0.0785
125 DACTYLITIS 77 0.0784
126 IMPAIRED HEALING 2576 0.0784
127 INTESTINAL ANASTOMOSIS 50 0.0776
128 HISTOPLASMOSIS DISSEMINATED 122 0.0768
129 SCIATICA 1222 0.0766
130 MATERNAL EXPOSURE TIMING UNSPECIFIED 274 0.0729
131 SPONDYLITIS 261 0.0717
132 IGA NEPHROPATHY 119 0.0717
133 THERAPEUTIC PRODUCT EFFECT DECREASED 3209 0.0716
134 ILEAL STENOSIS 126 0.0708
135 FOOT DEFORMITY 772 0.0696
136 PULMONARY FIBROSIS 1328 0.0692
137 ALANINE AMINOTRANSFERASE ABNORMAL 144 0.0682
138 ARTHROPATHY 3767 0.0677
139 BACK INJURY 730 0.0671
140 DRUG SPECIFIC ANTIBODY PRESENT 436 0.0670
141 SCLERITIS 106 0.0661
142 ANAL STENOSIS 35 0.0657
143 WALKING AID USER 433 0.0656
144 C-REACTIVE PROTEIN INCREASED 2362 0.0649
145 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 38 0.0643
146 ENTEROCUTANEOUS FISTULA 55 0.0624
147 JOINT DISLOCATION 651 0.0615
148 AXIAL SPONDYLOARTHRITIS 54 0.0614
149 BREAST CANCER STAGE II 511 0.0614
150 IRIDOCYCLITIS 193 0.0610
151 DRUG TOLERANCE 307 0.0606
152 LOWER LIMB FRACTURE 1161 0.0604
153 FEMALE GENITAL TRACT FISTULA 100 0.0585
154 POLYARTERITIS NODOSA 34 0.0582
155 LARGE INTESTINAL STENOSIS 116 0.0580
156 PRESCRIBED OVERDOSE 1107 0.0572
157 ENCEPHALITIS AUTOIMMUNE 75 0.0570
158 HIDRADENITIS 519 0.0569
159 MEAN CELL VOLUME DECREASED 87 0.0564
160 COELIAC DISEASE 549 0.0559
161 ERYTHRODERMIC PSORIASIS 46 0.0558
162 POUCHITIS 48 0.0557
163 INFUSION RELATED REACTION 3692 0.0556
164 GAIT INABILITY 1845 0.0552
165 VARICELLA ZOSTER VIRUS INFECTION 112 0.0540
166 EYE INJURY 164 0.0539
167 ULCER HAEMORRHAGE 365 0.0539
168 MEAN CELL HAEMOGLOBIN DECREASED 98 0.0535
169 PULMONARY SARCOIDOSIS 60 0.0534
170 BLOOD CHOLESTEROL INCREASED 2474 0.0530
171 RHEUMATOID ARTHRITIS 6004 0.0528
172 PROCTITIS 148 0.0528
173 HYPERSENSITIVITY PNEUMONITIS 60 0.0527
174 HIP ARTHROPLASTY 803 0.0524
175 GENITAL ULCERATION 40 0.0519
176 LIVER FUNCTION TEST INCREASED 1116 0.0519
177 GRANULOMA 173 0.0499
178 GRANULOMATOUS LIVER DISEASE 35 0.0497
179 FRACTURE DELAYED UNION 42 0.0497
180 LOWER RESPIRATORY TRACT INFECTION 2238 0.0492
181 URINARY TRACT DISORDER 221 0.0490
182 TREATMENT FAILURE 4032 0.0486
183 OSTEOARTHRITIS 2050 0.0483
184 BLOODY DISCHARGE 55 0.0481
185 HENOCH-SCHONLEIN PURPURA 105 0.0480
186 UVEITIS 647 0.0477
187 PARADOXICAL DRUG REACTION 170 0.0462
188 HEPATIC ENZYME INCREASED 3127 0.0458
189 NIGHT SWEATS 1476 0.0458
190 LYMPH NODE TUBERCULOSIS 34 0.0457
191 DEMYELINATION 187 0.0456
192 INFLAMMATION 2355 0.0456
193 PRESCRIBED UNDERDOSE 908 0.0455
194 DRUG INTOLERANCE 4363 0.0451
195 RASH VESICULAR 216 0.0446
196 BLISTER 2508 0.0446
197 HEPATIC CIRRHOSIS 838 0.0446
198 HYPOPNOEA 154 0.0443
199 MOBILITY DECREASED 3155 0.0439
200 GASTROINTESTINAL WALL THICKENING 65 0.0434
201 JOINT EFFUSION 298 0.0432
202 DERMATITIS PSORIASIFORM 88 0.0430
203 OSTEOPOROTIC FRACTURE 82 0.0428
204 CUSHINGOID 135 0.0420
205 DISCOMFORT 2558 0.0419
206 SKIN NECROSIS 217 0.0418
207 INTENTIONAL DOSE OMISSION 1186 0.0416
208 INTESTINAL DILATATION 55 0.0412
209 INFECTION REACTIVATION 47 0.0410
210 THERAPY NON-RESPONDER 1837 0.0408
211 SUSPECTED OFF LABEL USE 184 0.0407
212 CONGENITAL ANOMALY 313 0.0404
213 WHEELCHAIR USER 178 0.0400
214 NEUROENDOCRINE CARCINOMA OF THE SKIN 39 0.0398
215 PULMONARY TUBERCULOSIS 167 0.0391
216 WHEEZING 2316 0.0390
217 MYCOBACTERIAL INFECTION 67 0.0389
218 KNEE ARTHROPLASTY 812 0.0385
219 SWELLING 3540 0.0378
220 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 49 0.0372
221 ALLERGY TO CHEMICALS 46 0.0369
222 ANAL ABSCESS 199 0.0369
223 PNEUMONIA LEGIONELLA 59 0.0368
224 MATERNAL EXPOSURE DURING PREGNANCY 3273 0.0367
225 CYSTOID MACULAR OEDEMA 69 0.0366
226 NORMAL NEWBORN 199 0.0366
227 ANAL FISTULA 195 0.0365
228 STOMATITIS 2211 0.0364
229 TASTE DISORDER 735 0.0362
230 ALCOHOL POISONING 97 0.0362
231 INTENTIONAL PRODUCT USE ISSUE 3158 0.0360
232 MACULAR DEGENERATION 430 0.0360
233 CUTANEOUS T-CELL LYMPHOMA 45 0.0357
234 ADVERSE REACTION 471 0.0355
235 INJURY 2495 0.0355
236 ANKYLOSING SPONDYLITIS 466 0.0353
237 ILEOSTOMY 90 0.0352
238 SMALL INTESTINAL RESECTION 41 0.0352
239 CHRONIC SINUSITIS 132 0.0351
240 INTESTINAL FISTULA 49 0.0348
241 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 260 0.0346
242 MUSCULOSKELETAL STIFFNESS 3033 0.0346
243 JOINT SWELLING 4179 0.0346
244 JOINT STIFFNESS 899 0.0342
245 COLITIS ULCERATIVE 1528 0.0342
246 STENOSIS 64 0.0340
247 CHOLANGITIS SCLEROSING 69 0.0336
248 LUNG DISORDER 1641 0.0335
249 VULVOVAGINAL CANDIDIASIS 45 0.0333
250 BRONCHIECTASIS 224 0.0332
251 ILL-DEFINED DISORDER 2014 0.0331
252 HAEMORRHAGIC STROKE 257 0.0329
253 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 563 0.0328
254 MUSCULOSKELETAL PAIN 1658 0.0316
255 LATENT TUBERCULOSIS 66 0.0315
256 LIMB DEFORMITY 50 0.0314
257 ADRENAL INSUFFICIENCY 379 0.0312
258 OEDEMA 1690 0.0311
259 RADICULOPATHY 82 0.0311
260 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 82 0.0308
261 DRUG-INDUCED LIVER INJURY 962 0.0306
262 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 44 0.0306
263 ROAD TRAFFIC ACCIDENT 1280 0.0306
264 INFLAMMATORY MARKER INCREASED 150 0.0302
265 GENERAL PHYSICAL HEALTH DETERIORATION 3469 0.0300
266 FREQUENT BOWEL MOVEMENTS 799 0.0295
267 LIVER DISORDER 1301 0.0293
268 ANTINUCLEAR ANTIBODY POSITIVE 95 0.0292
269 SUDDEN HEARING LOSS 59 0.0291
270 ATYPICAL MYCOBACTERIAL INFECTION 41 0.0290
271 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2046 0.0287
272 INFLAMMATORY BOWEL DISEASE 281 0.0287
273 DISABILITY 564 0.0285
274 ERYTHEMA NODOSUM 100 0.0285
275 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1353 0.0281
276 MYOSITIS 252 0.0281
277 SARCOIDOSIS 132 0.0278
278 SLEEP DISORDER 1950 0.0276
279 INTESTINAL STENOSIS 116 0.0275
280 ALOPECIA AREATA 48 0.0273
281 DELIRIUM 941 0.0271
282 GENERAL SYMPTOM 203 0.0271
283 EPILEPSY 825 0.0270
284 MYELITIS TRANSVERSE 38 0.0270
285 SPINAL FUSION SURGERY 109 0.0268
286 MULTIPLE-DRUG RESISTANCE 82 0.0264
287 MACULAR OEDEMA 146 0.0260
288 HISTOPLASMOSIS 46 0.0260
289 MONOCYTE COUNT INCREASED 92 0.0253
290 HEPATITIS 648 0.0253
291 GASTROINTESTINAL DISORDER 2266 0.0253
292 KERATOPATHY 40 0.0253
293 INTERNATIONAL NORMALISED RATIO FLUCTUATION 52 0.0251
294 ARTHRITIS 1970 0.0250
295 RHINITIS 201 0.0249
296 OSTEOPOROSIS 1014 0.0246
297 EXPOSURE DURING PREGNANCY 1532 0.0246
298 LYME DISEASE 82 0.0246
299 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 58 0.0244
300 CERVICAL DYSPLASIA 53 0.0243
301 EAR INFECTION 643 0.0241
302 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 56 0.0241
303 ABDOMINAL DISCOMFORT 3971 0.0236
304 PAPILLOMA VIRAL INFECTION 38 0.0230
305 ARTHRITIS BACTERIAL 94 0.0229
306 DERMATOMYOSITIS 58 0.0229
307 INFECTION SUSCEPTIBILITY INCREASED 50 0.0228
308 DRY MOUTH 1853 0.0228
309 IMMUNODEFICIENCY 339 0.0227
310 TONGUE DISORDER 163 0.0225
311 ANTIPHOSPHOLIPID SYNDROME 36 0.0224
312 IMMUNOSUPPRESSION 197 0.0223
313 DEFORMITY 208 0.0222
314 CYTOMEGALOVIRUS COLITIS 51 0.0222
315 PLEURITIC PAIN 61 0.0221
316 ENTERITIS 139 0.0217
317 OCULAR DISCOMFORT 243 0.0216
318 OCULAR HYPERTENSION 42 0.0216
319 EAR PAIN 416 0.0214
320 INFECTION 3090 0.0213
321 ULCER 339 0.0213
322 RHEUMATIC DISORDER 41 0.0212
323 LYMPHOPROLIFERATIVE DISORDER 61 0.0207
324 ABSCESS INTESTINAL 44 0.0204
325 PHYSICAL DISABILITY 90 0.0203
326 ALOPECIA 3992 0.0203
327 PAROSMIA 152 0.0201
328 IMPAIRED QUALITY OF LIFE 288 0.0200
329 B-CELL LYMPHOMA 68 0.0200
330 GLOMERULONEPHRITIS 48 0.0196
331 GINGIVAL PAIN 156 0.0196
332 HYPOAESTHESIA 2926 0.0195
333 SUBILEUS 40 0.0192
334 LARGE INTESTINAL ULCER 52 0.0191
335 CREPITATIONS 57 0.0191
336 SOFT TISSUE INFECTION 35 0.0191
337 BASAL CELL CARCINOMA 297 0.0190
338 GROWTH RETARDATION 56 0.0190
339 PREGNANCY 380 0.0190
340 NODULE 245 0.0188
341 HYPERSENSITIVITY VASCULITIS 49 0.0186
342 CARDIAC MURMUR 161 0.0186
343 GENERALISED OEDEMA 230 0.0186
344 DYSPEPSIA 1823 0.0185
345 SINUSITIS 1890 0.0184
346 HYPERSENSITIVITY 3423 0.0184
347 JOINT ARTHROPLASTY 33 0.0184
348 THROMBOCYTOSIS 67 0.0183
349 THERAPY PARTIAL RESPONDER 283 0.0181
350 COLECTOMY 102 0.0180
351 TUBULOINTERSTITIAL NEPHRITIS 337 0.0180
352 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 38 0.0178
353 PUSTULE 42 0.0177
354 IRON DEFICIENCY 79 0.0175
355 MIGRAINE 1676 0.0175
356 INTERVERTEBRAL DISCITIS 33 0.0175
357 NECK PAIN 974 0.0174
358 HYPERCALCAEMIA 215 0.0174
359 PERIPHERAL SWELLING 2647 0.0172
360 HYPERTRANSAMINASAEMIA 119 0.0171
361 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 85 0.0170
362 FOOT OPERATION 84 0.0170
363 ADENOCARCINOMA 38 0.0169
364 SYNOVIAL CYST 78 0.0169
365 MYCOBACTERIUM AVIUM COMPLEX INFECTION 45 0.0167
366 CONTUSION 1591 0.0165
367 DRUG ERUPTION 290 0.0163
368 FEAR OF INJECTION 115 0.0161
369 SUBCUTANEOUS ABSCESS 77 0.0160
370 HYPERTENSION 3391 0.0160
371 BACK DISORDER 260 0.0160
372 RECTAL HAEMORRHAGE 686 0.0160
373 PRODUCT USE ISSUE 2991 0.0159
374 CUTANEOUS VASCULITIS 57 0.0156
375 CONDITION AGGRAVATED 4734 0.0156
376 DIARRHOEA HAEMORRHAGIC 145 0.0155
377 AMYOTROPHIC LATERAL SCLEROSIS 33 0.0153
378 PSORIASIS 2000 0.0153
379 TENDONITIS 236 0.0152
380 COLITIS 577 0.0152
381 URTICARIA 2509 0.0150
382 HEAD DISCOMFORT 265 0.0150
383 CONFUSIONAL STATE 2384 0.0147
384 RESPIRATORY DISORDER 439 0.0147
385 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 804 0.0146
386 SKIN ULCER 378 0.0146
387 GASTROOESOPHAGEAL REFLUX DISEASE 1159 0.0144
388 ADVERSE DRUG REACTION 1292 0.0144
389 PHOTOPHOBIA 270 0.0143
390 AMNESIA 933 0.0143
391 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 242 0.0142
392 ADVERSE EVENT 1311 0.0142
393 DERMATITIS EXFOLIATIVE GENERALISED 49 0.0141
394 MENINGITIS ASEPTIC 63 0.0140
395 LUNG ADENOCARCINOMA 42 0.0139
396 KLEBSIELLA INFECTION 70 0.0138
397 APHTHOUS ULCER 106 0.0137
398 ABSCESS 218 0.0136
399 UPPER RESPIRATORY TRACT INFECTION 631 0.0136
400 THERAPEUTIC RESPONSE DECREASED 822 0.0135
401 SKIN INFECTION 152 0.0135
402 MEDICATION ERROR 751 0.0135
403 IRITIS 41 0.0135
404 NASOPHARYNGITIS 2458 0.0133
405 FISTULA 148 0.0132
406 MUSCULAR WEAKNESS 1495 0.0131
407 ULCERATIVE KERATITIS 36 0.0131
408 ARTHRALGIA 5415 0.0130
409 LOSS OF EMPLOYMENT 39 0.0129
410 QUALITY OF LIFE DECREASED 173 0.0129
411 KERATITIS 39 0.0128
412 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 49 0.0128
413 OSTEOMYELITIS 232 0.0128
414 PNEUMOCYSTIS JIROVECII PNEUMONIA 128 0.0127
415 DRUG LEVEL BELOW THERAPEUTIC 70 0.0127
416 IMPAIRED WORK ABILITY 271 0.0127
417 HAEMATOCHEZIA 692 0.0125
418 COLITIS MICROSCOPIC 59 0.0124
419 ENDOMETRIOSIS 59 0.0124
420 BACTERIAL SEPSIS 40 0.0123
421 GASTROINTESTINAL INFLAMMATION 96 0.0122
422 DRUG LEVEL DECREASED 124 0.0122
423 MEMORY IMPAIRMENT 1672 0.0122
424 WEIGHT FLUCTUATION 127 0.0121
425 MUSCULOSKELETAL DISORDER 231 0.0121
426 HEPATOTOXICITY 270 0.0121
427 ADENOVIRUS INFECTION 35 0.0121
428 VAGINAL DISCHARGE 122 0.0120
429 ORGANISING PNEUMONIA 59 0.0119
430 ABDOMINAL PAIN UPPER 2448 0.0119
431 PLATELET COUNT INCREASED 155 0.0119
432 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 345 0.0118
433 WEIGHT INCREASED 2618 0.0117
434 INTESTINAL PERFORATION 131 0.0117
435 WOUND COMPLICATION 40 0.0116
436 HEPATIC ENZYME ABNORMAL 58 0.0116
437 TONGUE ULCERATION 39 0.0115
438 EXPOSURE VIA SKIN CONTACT 298 0.0115
439 HISTIOCYTOSIS HAEMATOPHAGIC 34 0.0114
440 ASTHMA 1291 0.0114
441 ALTERED STATE OF CONSCIOUSNESS 245 0.0113
442 BK VIRUS INFECTION 38 0.0113
443 SMALL INTESTINAL OBSTRUCTION 137 0.0111
444 ABDOMINAL ABSCESS 49 0.0111
445 HERPES SIMPLEX 72 0.0111
446 HEPATIC STEATOSIS 206 0.0110
447 RASH 4812 0.0110
448 ORAL DISCOMFORT 153 0.0110
449 CLOSTRIDIUM DIFFICILE INFECTION 240 0.0110
450 ENCEPHALITIS 76 0.0110
451 DIPLOPIA 283 0.0109
452 EPSTEIN-BARR VIRUS INFECTION 68 0.0109
453 CLOSTRIDIUM DIFFICILE COLITIS 115 0.0108
454 SENSITIVITY TO WEATHER CHANGE 57 0.0108
455 ORAL CANDIDIASIS 142 0.0108
456 PRODUCT USE IN UNAPPROVED INDICATION 2666 0.0107
457 GUILLAIN-BARRE SYNDROME 52 0.0107
458 IRON DEFICIENCY ANAEMIA 99 0.0107
459 JOINT INJURY 229 0.0107
460 HYPOCALCAEMIA 202 0.0107
461 SPINAL PAIN 125 0.0107
462 ABSCESS LIMB 45 0.0105
463 TONSILLITIS 55 0.0105
464 PRESYNCOPE 256 0.0105
465 GASTROENTERITIS VIRAL 190 0.0105
466 PRE-ECLAMPSIA 50 0.0105
467 MUSCLE SPASTICITY 129 0.0105
468 VASCULITIS 121 0.0104
469 GASTROINTESTINAL INFECTION 93 0.0104
470 DECREASED APPETITE 2404 0.0103
471 SEPTIC SHOCK 449 0.0103
472 ASCITES 302 0.0103
473 IMMUNE THROMBOCYTOPENIA 47 0.0103
474 MALIGNANT MELANOMA 135 0.0101
475 SYMPTOM RECURRENCE 60 0.0100
476 HAEMATEMESIS 254 0.0100
477 OFF LABEL USE 8671 0.0099
478 PARAESTHESIA ORAL 142 0.0098
479 FOOD INTOLERANCE 36 0.0098
480 HYPOALBUMINAEMIA 76 0.0098
481 WHITE BLOOD CELL COUNT INCREASED 374 0.0097
482 MENINGITIS 65 0.0097
483 OESOPHAGEAL CANDIDIASIS 38 0.0095
484 PYREXIA 3281 0.0095
485 PULMONARY TOXICITY 67 0.0095
486 DEPRESSION 2154 0.0095
487 ABDOMINAL PAIN 2202 0.0095
488 SKIN REACTION 133 0.0094
489 PEMPHIGOID 71 0.0094
490 OPTIC NEURITIS 85 0.0093
491 PAIN IN EXTREMITY 2736 0.0093
492 INJECTION SITE REACTION 636 0.0092
493 SKIN PAPILLOMA 37 0.0092
494 HERPES VIRUS INFECTION 53 0.0092
495 PAIN 5648 0.0092
496 WOUND SECRETION 36 0.0092
497 STREPTOCOCCAL INFECTION 51 0.0092
498 PAPILLOEDEMA 41 0.0091
499 CHOLANGITIS 56 0.0090
500 PARAESTHESIA 1420 0.0090
501 HAEMATURIA 308 0.0090
502 HYPERTENSIVE CRISIS 100 0.0090
503 PSEUDOMONAS INFECTION 77 0.0090
504 POST PROCEDURAL INFECTION 73 0.0090
505 TINNITUS 412 0.0090
506 FURUNCLE 70 0.0088
507 AUTOIMMUNE THYROIDITIS 33 0.0087
508 CHEST PAIN 1602 0.0086
509 PNEUMONIA 2787 0.0086
510 OEDEMA PERIPHERAL 1041 0.0085
511 RASH PRURITIC 462 0.0085
512 PANCREATITIS 450 0.0085
513 MOUTH ULCERATION 178 0.0084
514 VITAMIN B12 DEFICIENCY 34 0.0084
515 ATELECTASIS 81 0.0084
516 MALAISE 3675 0.0084
517 INSOMNIA 2222 0.0083
518 MUCOUS STOOLS 41 0.0083
519 UNDERDOSE 604 0.0083
520 DRUG INEFFECTIVE 10824 0.0082
521 RENAL CELL CARCINOMA 40 0.0082
522 VISUAL IMPAIRMENT 1004 0.0081
523 BONE DENSITY DECREASED 252 0.0080
524 ANAL FISSURE 43 0.0080
525 LYMPHADENOPATHY 283 0.0080
526 MUSCLE SPASMS 1462 0.0080
527 HYPOGAMMAGLOBULINAEMIA 52 0.0079
528 BLINDNESS 322 0.0079
529 DEFAECATION URGENCY 55 0.0078
530 SKIN LESION 215 0.0078
531 AUTOIMMUNE HEPATITIS 54 0.0078
532 ERYSIPELAS 39 0.0078
533 GASTROINTESTINAL TOXICITY 37 0.0077
534 TENDERNESS 80 0.0077
535 EAR DISORDER 35 0.0076
536 LYMPHOPENIA 108 0.0076
537 SQUAMOUS CELL CARCINOMA OF SKIN 46 0.0076
538 ASPERGILLUS INFECTION 50 0.0076
539 MATERNAL EXPOSURE BEFORE PREGNANCY 52 0.0076
540 UROSEPSIS 70 0.0076
541 FOETAL DEATH 39 0.0075
542 TACHYCARDIA 664 0.0075
543 HEPATITIS B 45 0.0075
544 ENTEROCOCCAL INFECTION 36 0.0074
545 DIFFUSE LARGE B-CELL LYMPHOMA 57 0.0074
546 VOMITING 3474 0.0074
547 ANAL INCONTINENCE 66 0.0073
548 FATIGUE 5699 0.0073
549 EYE INFLAMMATION 69 0.0072
550 PRODUCT DISTRIBUTION ISSUE 67 0.0072
551 LABORATORY TEST ABNORMAL 213 0.0072
552 PULMONARY MASS 107 0.0072
553 EYE PAIN 403 0.0071
554 GESTATIONAL DIABETES 34 0.0071
555 DECREASED IMMUNE RESPONSIVENESS 70 0.0071
556 ARTHRITIS INFECTIVE 33 0.0071
557 RESPIRATORY TRACT INFECTION 185 0.0071
558 GAIT DISTURBANCE 1332 0.0070
559 FLANK PAIN 65 0.0069
560 SKIN DISORDER 231 0.0069
561 SQUAMOUS CELL CARCINOMA 64 0.0068
562 OSTEOPENIA 103 0.0068
563 HEADACHE 4231 0.0067
564 ABDOMINAL DISTENSION 699 0.0067
565 INTESTINAL RESECTION 36 0.0067
566 COVID-19 PNEUMONIA 79 0.0067
567 PROCTALGIA 43 0.0067
568 ESCHERICHIA INFECTION 55 0.0067
569 SKIN PLAQUE 56 0.0066
570 SWOLLEN TONGUE 207 0.0066
571 BRONCHITIS 488 0.0066
572 HERPES ZOSTER 378 0.0066
573 ANAPHYLACTIC REACTION 363 0.0066
574 DIARRHOEA 4211 0.0065
575 PRODUCT PRESCRIBING ISSUE 142 0.0065
576 HEPATIC CYTOLYSIS 83 0.0065
577 HIP SURGERY 35 0.0065
578 LIMB DISCOMFORT 199 0.0064
579 INTERSTITIAL LUNG DISEASE 311 0.0064
580 LOW BIRTH WEIGHT BABY 51 0.0064
581 HAEMATOCRIT DECREASED 127 0.0064
582 CYTOMEGALOVIRUS INFECTION 106 0.0064
583 POSTOPERATIVE WOUND INFECTION 43 0.0064
584 ASTHENIA 2390 0.0063
585 SPINAL DISORDER 60 0.0063
586 PRURITUS 2429 0.0063
587 NEUROLOGICAL SYMPTOM 36 0.0063
588 WEIGHT DECREASED 1756 0.0063
589 ASPARTATE AMINOTRANSFERASE INCREASED 333 0.0063
590 ENTEROCOLITIS 36 0.0062
591 SPLENOMEGALY 73 0.0062
592 PLEURISY 37 0.0062
593 KNEE OPERATION 61 0.0062
594 FOETAL EXPOSURE DURING PREGNANCY 504 0.0062
595 BRONCHOPULMONARY ASPERGILLOSIS 48 0.0062
596 NEOPLASM 71 0.0062
597 THERAPEUTIC RESPONSE CHANGED 39 0.0061
598 CONJUNCTIVITIS 114 0.0061
599 FEELING HOT 375 0.0061
600 PAPULE 43 0.0061
601 NEOPLASM MALIGNANT 407 0.0061
602 SEPSIS 678 0.0061
603 METASTASES TO LYMPH NODES 41 0.0061
604 RED BLOOD CELL COUNT DECREASED 173 0.0060
605 CARDIO-RESPIRATORY ARREST 253 0.0060
606 RETINAL HAEMORRHAGE 43 0.0060
607 DRUG RESISTANCE 155 0.0060
608 STAPHYLOCOCCAL INFECTION 199 0.0060
609 ODYNOPHAGIA 36 0.0060
610 PRODUCT SUPPLY ISSUE 43 0.0060
611 CAESAREAN SECTION 70 0.0060
612 ALANINE AMINOTRANSFERASE INCREASED 367 0.0060
613 LIVER FUNCTION TEST ABNORMAL 173 0.0059
614 REBOUND EFFECT 67 0.0059
615 ECZEMA 309 0.0059
616 DIZZINESS 2945 0.0059
617 HYPOKALAEMIA 272 0.0059
618 SWELLING OF EYELID 37 0.0059
619 COVID-19 1025 0.0058
620 ABORTION INDUCED 55 0.0058
621 MALNUTRITION 65 0.0058
622 ILEUS 72 0.0058
623 TOOTH ABSCESS 58 0.0057
624 BOWEL MOVEMENT IRREGULARITY 43 0.0056
625 MULTIPLE FRACTURES 92 0.0056
626 DISEASE RECURRENCE 266 0.0056
627 ACCIDENTAL OVERDOSE 204 0.0056
628 LYMPHOMA 86 0.0056
629 PNEUMONIA BACTERIAL 51 0.0056
630 MASS 77 0.0055
631 DEVICE MALFUNCTION 387 0.0055
632 CANDIDA INFECTION 93 0.0055
633 SCOLIOSIS 34 0.0055
634 TRANSAMINASES INCREASED 122 0.0055
635 DERMATITIS ALLERGIC 69 0.0055
636 LEUKOPENIA 273 0.0055
637 COMA 258 0.0054
638 PREMATURE DELIVERY 86 0.0054
639 DRUG EFFECT LESS THAN EXPECTED 80 0.0054
640 BLOOD DISORDER 43 0.0054
641 CELLULITIS 270 0.0054
642 NAUSEA 4239 0.0054
643 MYOCARDITIS 61 0.0053
644 FLUID RETENTION 270 0.0053
645 CATARACT 313 0.0053
646 PRODUCT QUALITY ISSUE 705 0.0052
647 NEPHROPATHY TOXIC 58 0.0052
648 GLAUCOMA 99 0.0051
649 PLEURAL EFFUSION 312 0.0051
650 PROCEDURAL PAIN 142 0.0051
651 RASH PUSTULAR 37 0.0051
652 NEUTROPHIL COUNT INCREASED 52 0.0051
653 SURGERY 296 0.0050
654 POLYNEUROPATHY 60 0.0050
655 IMMUNE SYSTEM DISORDER 66 0.0050
656 AORTIC ANEURYSM 38 0.0050
657 BREAST CANCER STAGE I 46 0.0050
658 DUODENAL ULCER 35 0.0050
659 GASTRIC DISORDER 169 0.0049
660 CARDIOVASCULAR DISORDER 125 0.0049
661 BLOOD PRESSURE SYSTOLIC INCREASED 96 0.0049
662 LYMPHOEDEMA 34 0.0049
663 CYST 61 0.0049
664 GASTROINTESTINAL PAIN 54 0.0049
665 DYSPNOEA 2771 0.0049
666 THERAPY INTERRUPTED 349 0.0049
667 SECRETION DISCHARGE 61 0.0049
668 ORAL HERPES 95 0.0049
669 DEEP VEIN THROMBOSIS 316 0.0049
670 INCORRECT PRODUCT ADMINISTRATION DURATION 105 0.0048
671 TOOTH EXTRACTION 60 0.0048
672 FEMUR FRACTURE 148 0.0048
673 BACTERIAL INFECTION 89 0.0048
674 LARGE INTESTINE POLYP 33 0.0048
675 INTESTINAL OBSTRUCTION 179 0.0047
676 SENSORY LOSS 38 0.0047
677 VITAMIN D DEFICIENCY 46 0.0047
678 NIGHTMARE 162 0.0047
679 PHARYNGITIS 58 0.0047
680 BLOOD TEST ABNORMAL 65 0.0046
681 FACIAL PARALYSIS 39 0.0046
682 CARPAL TUNNEL SYNDROME 64 0.0046
683 BLOOD ALBUMIN DECREASED 36 0.0045
684 BACTERAEMIA 53 0.0045
685 EOSINOPHILIA 78 0.0044
686 INCONTINENCE 47 0.0044
687 HOSPITALISATION 682 0.0044
688 ANXIETY 1262 0.0044
689 LUNG INFILTRATION 39 0.0044
690 UNEVALUABLE EVENT 334 0.0044
691 ABORTION SPONTANEOUS 176 0.0044
692 APPENDICITIS 41 0.0044
693 PYELONEPHRITIS 38 0.0044
694 RENAL TUBULAR NECROSIS 43 0.0044
695 VERTIGO 266 0.0044
696 RETINAL DETACHMENT 40 0.0043
697 CYTOPENIA 53 0.0043
698 SKIN CANCER 93 0.0043
699 MUCOSAL INFLAMMATION 113 0.0043
700 SARS-COV-2 TEST POSITIVE 57 0.0043
701 NERVE INJURY 47 0.0042
702 DERMATITIS 88 0.0042
703 LEUKOCYTOSIS 76 0.0042
704 TREATMENT NONCOMPLIANCE 229 0.0042
705 PURPURA 37 0.0042
706 GASTROENTERITIS 61 0.0042
707 BODY TEMPERATURE INCREASED 85 0.0042
708 INTERVERTEBRAL DISC PROTRUSION 91 0.0042
709 RESPIRATORY SYNCYTIAL VIRUS INFECTION 36 0.0041
710 POST PROCEDURAL COMPLICATION 79 0.0041
711 ASPIRATION 45 0.0041
712 TOOTH INFECTION 54 0.0041
713 BRAIN NEOPLASM 37 0.0040
714 VIRAL INFECTION 134 0.0040
715 GROIN PAIN 35 0.0040
716 TOXIC SKIN ERUPTION 40 0.0040
717 CHILLS 465 0.0040
718 LOCALISED INFECTION 95 0.0039
719 PANCYTOPENIA 216 0.0039
720 GASTROINTESTINAL CARCINOMA 35 0.0039
721 DEVICE RELATED INFECTION 59 0.0038
722 THERAPEUTIC RESPONSE SHORTENED 126 0.0038
723 OSTEONECROSIS OF JAW 94 0.0038
724 DEAFNESS 99 0.0038
725 ERYTHEMA 774 0.0038
726 DIVERTICULITIS 103 0.0037
727 BLOOD IRON DECREASED 44 0.0037
728 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 663 0.0037
729 SYNCOPE 368 0.0037
730 DRUG DOSE OMISSION BY DEVICE 287 0.0037
731 FALL 1210 0.0036
732 HIATUS HERNIA 47 0.0036
733 COLON CANCER 54 0.0036
734 BONE DISORDER 66 0.0036
735 PULMONARY EMBOLISM 343 0.0036
736 ISCHAEMIC STROKE 64 0.0036
737 HEPATOMEGALY 34 0.0035
738 PREMATURE BABY 103 0.0034
739 CARDIAC FAILURE 274 0.0034
740 MYALGIA 580 0.0034
741 DEVICE DEFECTIVE 59 0.0034
742 PNEUMONITIS 92 0.0034
743 HEMIPARESIS 57 0.0034
744 KIDNEY INFECTION 66 0.0034
745 URINARY TRACT INFECTION 570 0.0033
746 SCAB 38 0.0033
747 CYSTITIS 106 0.0033
748 ATAXIA 39 0.0033
749 THROMBOCYTOPENIA 367 0.0033
750 ACCIDENTAL EXPOSURE TO PRODUCT 337 0.0033
751 BRAIN FOG 51 0.0033
752 CHOLECYSTECTOMY 37 0.0032
753 PERITONITIS 67 0.0032
754 ILLNESS 332 0.0032
755 CARDIOMYOPATHY 47 0.0032
756 OSTEONECROSIS 104 0.0032
757 GASTRIC ULCER 60 0.0032
758 BLOOD CREATININE INCREASED 206 0.0032
759 LOSS OF CONSCIOUSNESS 401 0.0031
760 HAEMORRHOIDS 61 0.0031
761 CHOLESTASIS 60 0.0031
762 PALPITATIONS 363 0.0031
763 HAEMOGLOBIN DECREASED 316 0.0031
764 ERECTILE DYSFUNCTION 79 0.0031
765 NERVOUS SYSTEM DISORDER 96 0.0031
766 RASH MACULO-PAPULAR 68 0.0031
767 PHOTOSENSITIVITY REACTION 50 0.0030
768 SPINAL OPERATION 37 0.0030
769 RENAL IMPAIRMENT 250 0.0030
770 MYELODYSPLASTIC SYNDROME 43 0.0030
771 ABDOMINAL PAIN LOWER 75 0.0030
772 RESPIRATORY TRACT CONGESTION 47 0.0030
773 ACUTE MYELOID LEUKAEMIA 46 0.0029
774 PROTEINURIA 56 0.0029
775 DEVICE MECHANICAL ISSUE 40 0.0029
776 FACE OEDEMA 49 0.0029
777 PERICARDIAL EFFUSION 67 0.0029
778 INTRAOCULAR PRESSURE INCREASED 37 0.0029
779 SWELLING FACE 188 0.0029
780 ACUTE RESPIRATORY DISTRESS SYNDROME 51 0.0029
781 NEPHROLITHIASIS 132 0.0029
782 RESPIRATORY FAILURE 209 0.0029
783 BACK PAIN 665 0.0029
784 MULTIPLE ORGAN DYSFUNCTION SYNDROME 81 0.0029
785 PANCREATITIS ACUTE 64 0.0028
786 SPINAL FRACTURE 57 0.0028
787 MULTIPLE SCLEROSIS 135 0.0028
788 DIABETES MELLITUS 215 0.0028
789 PRODUCT SUBSTITUTION ISSUE 162 0.0028
790 BLOOD PRESSURE INCREASED 428 0.0028
791 NEEDLE ISSUE 81 0.0028
792 BLINDNESS UNILATERAL 39 0.0028
793 COUGH 772 0.0028
794 GASTRITIS 72 0.0027
795 DISSEMINATED INTRAVASCULAR COAGULATION 38 0.0027
796 SENSORY DISTURBANCE 43 0.0027
797 BEDRIDDEN 35 0.0027
798 BREAST CANCER 246 0.0026
799 INCORRECT DOSE ADMINISTERED BY DEVICE 69 0.0026
800 ANAEMIA 502 0.0026
801 FEELING JITTERY 50 0.0026
802 ANGIOEDEMA 116 0.0026
803 INFLUENZA 292 0.0026
804 LUNG NEOPLASM MALIGNANT 107 0.0026
805 DRY EYE 129 0.0026
806 OROPHARYNGEAL PAIN 233 0.0025
807 ACUTE MYOCARDIAL INFARCTION 74 0.0025
808 DYSGEUSIA 186 0.0025
809 CEREBRAL HAEMORRHAGE 89 0.0025
810 PAIN IN JAW 69 0.0024
811 SOMNOLENCE 489 0.0024
812 DYSSTASIA 70 0.0024
813 GAMMA-GLUTAMYLTRANSFERASE INCREASED 53 0.0024
814 DEPRESSED MOOD 125 0.0024
815 HYPERTHYROIDISM 34 0.0023
816 FRACTURE 44 0.0023
817 MENTAL DISORDER 101 0.0023
818 INFLUENZA LIKE ILLNESS 191 0.0023
819 VISION BLURRED 316 0.0023
820 DISEASE PROGRESSION 270 0.0023
821 HYPOKINESIA 33 0.0023
822 ACUTE KIDNEY INJURY 347 0.0023
823 NEURALGIA 55 0.0023
824 INTENTIONAL PRODUCT MISUSE 197 0.0022
825 TOXIC EPIDERMAL NECROLYSIS 34 0.0022
826 FOOT FRACTURE 42 0.0022
827 DYSPHONIA 128 0.0022
828 ORAL PAIN 49 0.0022
829 ACUTE RESPIRATORY FAILURE 42 0.0022
830 PRODUCTIVE COUGH 104 0.0022
831 LIMB INJURY 59 0.0022
832 RASH ERYTHEMATOUS 103 0.0022
833 PRODUCT DOSE OMISSION IN ERROR 61 0.0022
834 ANKLE FRACTURE 33 0.0021
835 RENAL DISORDER 99 0.0021
836 MOVEMENT DISORDER 68 0.0021
837 FUNGAL INFECTION 70 0.0021
838 EYE DISORDER 68 0.0021
839 POOR QUALITY SLEEP 44 0.0020
840 MUSCULOSKELETAL DISCOMFORT 35 0.0020
841 PRODUCT AVAILABILITY ISSUE 46 0.0020
842 DYSURIA 74 0.0020
843 RIB FRACTURE 41 0.0020
844 LYMPHOCYTE COUNT DECREASED 35 0.0020
845 INJECTION SITE RASH 60 0.0020
846 NEUROPATHY PERIPHERAL 185 0.0019
847 THROMBOSIS 155 0.0019
848 RASH PAPULAR 43 0.0019
849 HERNIA 37 0.0019
850 OCULAR HYPERAEMIA 90 0.0019
851 THERAPY CESSATION 97 0.0019
852 PNEUMONIA ASPIRATION 46 0.0018
853 DYSPNOEA EXERTIONAL 69 0.0018
854 BLOOD ALKALINE PHOSPHATASE INCREASED 45 0.0018
855 OVERDOSE 390 0.0018
856 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 94 0.0018
857 CHOLELITHIASIS 59 0.0018
858 PRODUCT DOSE OMISSION ISSUE 526 0.0018
859 EATING DISORDER 38 0.0018
860 ANGINA PECTORIS 51 0.0018
861 EYE SWELLING 66 0.0018
862 CEREBRAL INFARCTION 43 0.0018
863 ANAPHYLACTIC SHOCK 45 0.0017
864 PRODUCT DISPENSING ERROR 38 0.0017
865 DRUG EFFECT INCOMPLETE 63 0.0017
866 FEEDING DISORDER 35 0.0017
867 RHINORRHOEA 111 0.0017
868 CEREBROVASCULAR ACCIDENT 286 0.0017
869 INJECTION SITE PRURITUS 111 0.0017
870 DRUG INTERACTION 262 0.0016
871 HEPATIC FUNCTION ABNORMAL 61 0.0016
872 HYPOTENSION 322 0.0016
873 EYE IRRITATION 92 0.0016
874 HAEMORRHAGE 164 0.0016
875 FAECES DISCOLOURED 34 0.0016
876 HYPOTHYROIDISM 50 0.0016
877 NASAL CONGESTION 92 0.0016
878 BLOOD POTASSIUM DECREASED 47 0.0016
879 HAEMOPTYSIS 43 0.0015
880 DEVICE DELIVERY SYSTEM ISSUE 42 0.0015
881 SKIN EXFOLIATION 129 0.0015
882 RESPIRATORY DISTRESS 42 0.0015
883 COLORECTAL CANCER 72 0.0015
884 BLOOD CREATINE PHOSPHOKINASE INCREASED 43 0.0015
885 INJECTION SITE SWELLING 114 0.0015
886 HYPOGLYCAEMIA 72 0.0015
887 TRANSIENT ISCHAEMIC ATTACK 50 0.0015
888 RENAL FAILURE 196 0.0015
889 CONSTIPATION 321 0.0015
890 BREAST CANCER FEMALE 39 0.0015
891 GASTROINTESTINAL HAEMORRHAGE 121 0.0014
892 BLOOD BILIRUBIN INCREASED 39 0.0014
893 PROSTATE CANCER 116 0.0014
894 DERMATITIS ATOPIC 76 0.0014
895 NEUTROPENIA 195 0.0014
896 DEMENTIA 40 0.0014
897 BURNING SENSATION 99 0.0014
898 WHITE BLOOD CELL COUNT DECREASED 153 0.0014
899 DRUG EFFECT DECREASED 76 0.0014
900 SEIZURE 162 0.0014
901 LACRIMATION INCREASED 42 0.0014
902 PANCREATIC CARCINOMA 40 0.0014
903 ENCEPHALOPATHY 34 0.0014
904 ACNE 103 0.0014
905 LETHARGY 78 0.0014
906 LIP SWELLING 45 0.0013
907 HAEMATOMA 35 0.0013
908 INJECTION SITE PAIN 414 0.0013
909 DEATH 1148 0.0013
910 FEELING ABNORMAL 319 0.0013
911 PALLOR 36 0.0013
912 INJECTION SITE ERYTHEMA 162 0.0013
913 CHRONIC KIDNEY DISEASE 99 0.0013
914 THERAPEUTIC RESPONSE UNEXPECTED 58 0.0013
915 APHASIA 39 0.0013
916 HYPOPHAGIA 33 0.0013
917 ATRIAL FIBRILLATION 124 0.0013
918 FLATULENCE 72 0.0013
919 DEVICE DIFFICULT TO USE 84 0.0013
920 HYPERHIDROSIS 163 0.0013
921 INJECTION SITE BRUISING 100 0.0013
922 PSYCHOTIC DISORDER 37 0.0013
923 PANIC ATTACK 45 0.0012
924 CARDIAC FAILURE CONGESTIVE 99 0.0012
925 RASH MACULAR 43 0.0012
926 FEBRILE NEUTROPENIA 81 0.0012
927 TREMOR 199 0.0012
928 ARRHYTHMIA 56 0.0012
929 DEVICE LEAKAGE 51 0.0012
930 TOXICITY TO VARIOUS AGENTS 198 0.0012
931 HYPONATRAEMIA 66 0.0012
932 PULMONARY OEDEMA 52 0.0012
933 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 39 0.0012
934 INJECTION SITE HAEMORRHAGE 92 0.0012
935 HIP FRACTURE 37 0.0011
936 DYSPHAGIA 109 0.0011
937 SUICIDAL IDEATION 105 0.0011
938 URINARY RETENTION 38 0.0011
939 BALANCE DISORDER 98 0.0011
940 CARDIAC DISORDER 106 0.0011
941 METABOLIC ACIDOSIS 36 0.0011
942 VISUAL ACUITY REDUCED 37 0.0011
943 COGNITIVE DISORDER 51 0.0011
944 RENAL CANCER 52 0.0011
945 INJECTION SITE MASS 39 0.0011
946 SPEECH DISORDER 55 0.0010
947 CRYING 38 0.0010
948 SKIN DISCOLOURATION 48 0.0010
949 HYPERGLYCAEMIA 38 0.0010
950 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 47 0.0010
951 THROAT IRRITATION 45 0.0010
952 DEVICE ISSUE 87 0.0010
953 RHABDOMYOLYSIS 40 0.0010
954 POLLAKIURIA 39 0.0009
955 CHEST DISCOMFORT 93 0.0009
956 BLADDER CANCER 53 0.0009
957 IRRITABILITY 53 0.0009
958 HEART RATE INCREASED 87 0.0009
959 EPISTAXIS 65 0.0009
960 DRY SKIN 115 0.0009
961 SUICIDE ATTEMPT 52 0.0009
962 NO ADVERSE EVENT 154 0.0008
963 DEHYDRATION 113 0.0008
964 MYOCARDIAL INFARCTION 147 0.0008
965 HYPOACUSIS 36 0.0008
966 FLUSHING 80 0.0008
967 HOT FLUSH 59 0.0008
968 PRODUCT STORAGE ERROR 67 0.0008
969 INCORRECT DOSE ADMINISTERED 172 0.0008
970 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 146 0.0007
971 BONE PAIN 40 0.0007
972 CARDIAC ARREST 55 0.0007
973 DISTURBANCE IN ATTENTION 34 0.0006
974 SKIN BURNING SENSATION 40 0.0006
975 AGITATION 41 0.0006
976 BLOOD PRESSURE DECREASED 33 0.0005
977 HALLUCINATION 34 0.0005
978 DRUG DEPENDENCE 71 0.0004
979 COMPLETED SUICIDE 36 0.0004
980 PLATELET COUNT DECREASED 36 0.0003
981 BLOOD GLUCOSE INCREASED 54 0.0003
982 EMOTIONAL DISTRESS 33 0.0003